References For Ginkgo biloba - E-jeen product - Hekma Center
Mini Cart
  • Empty cart

    No products in the cart.

References For Ginkgo biloba – E-jeen product

References For Ginkgo biloba – E-jeen product

– Agha AM, El-Fattah AA, Al-Zuhair HH, Al-Rikabi AC. Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity. J Exp Clin Cancer Res 2001.

– Bagnis C, Deray G, Dubois M et al. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist. Nephrol Dial Transplant 1996.

– Barth SA, Inselmann G, Engemann R, Heidemann HT. Influences of Ginkgo biloba on cyclosporin A–induced lipid peroxidation in human liver microsomes in comparison to Vitamin E, glutathione and N-acetylcysteine. Biochem Pharmacol 1991.

– Becker K, Braquet P, Forster W. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB 2. Biomed Biochim Acta 1988.

– Benjamin J, Muir T, Briggs K, et al. A case of cerebral haemorrhage – can Ginkgo biloba be implicated? Postgrad. Med. J., 77:112-113, 2001.

– Bent S. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med. 2005 Jul;20(7):657-61.

– Brondino N, et al. A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Evid Based Complement Alternat Med,2013.

– Brouwer CA, Gietema JA, van den Berg MP et al. Long-term cardiac follow-up in survivors of a malignant bone tumour. Ann Oncol 2006.

– Burns NR. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Hum Psychopharmacol 2006 Jan;21(1):27-37.

– Chan ALF, Leung HWC, Wu J-W, et al. Risk of hemorrhage associated with coprescriptions for Ginkgo biloba and antiplatelet or anticoagularnt drugs. J. Altern. Compl. Med., 2011; 17(6):513-517.

– Dardano A, Ballardin M, Caraccio N, et al. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131. Thyroid.2011; 22(3):318-324.

– Dardano A, Ballardin M, Ferdeghini M, et al. Anticlastogenic effect of Ginkgo biloba extraact in Graves’ disease patients receiving radioiodine therapy. J. Clin. Endocrin. Metab., 2007; 92(11):4286-4289.

– DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000.

– DeFeudis FV. Ginkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. Amsterdam: Elsevier; 1991; pp. 143–146.

– Destro MWB, Speranzini MB, Cavalheiro Filho C, et al. Bilateral haematoma after rhytidoplasty and blepharoplasty following chronic use of Ginkgo biloba. Br. Assoc. Plat.Surg., 2005; 58:100-101.

– Fessenden JM, Wittenborn W, Clarke L. Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg.2001;67(1):33–35.

– Foegh ML, Khirabadi BS, Rowles JR et al. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. Transplantation 1986.

– Fong KC, Kinnear PE. Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion. Postgrad Med J 2003;79:531-532.

– Fukaya H, Kanno H. [Experimental studies of the protective effect of Ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]. Nippon Jibiinkoka Gakkai Kaiho 1999.

– German Commission E monograph, Trockenextrakt (35–67:1) aus Ginkgo-biloba-Blättern Extrakt mit Aceton-Wasser. Bundesanzeiger, 1994, 46:7361–7362.

– Grino JM. BN 52021: A platelet activating factor antagonist for preventing posttransplant renal failure. Ann. Int. Med., 1994; 121:345-347.

– Gurley BJ, Gardner SF, Hubbard MA et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John’s wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005.

– Issing W. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med. 2005 Feb;11(1):155-60.

– Jiang X, Williams KM, Liauw WS et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59:425-432.

– Johnson SK et al. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial. Explore (NY) 2006 Jan;2(1):19-24.

– Kanowski S et al. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry. 2003 Nov;36(6):297-30.

– Kanowski S et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi- infarct dementia. Phytomedicine 1997;4:3-13.

– Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011 May;31(5):490-502.

– Kohler S, Funk P, Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul Fibrinolysis 2004;15:303-309.


– Lanthony P. The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study. J Fr Ophtalmol 1988;11:671-674.

– Le Bars PL et al. A placebo-controlled, double blind, randomized trial of an extract of Gingko biloba for dementia. North American EGb Study group. JAMA 1997;278:1327-13232.

– Mahmoud F, Abul H, Onadeko B et al. In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: comparison with cyclosporin A. Jpn J Pharmacol 2000.

– Mazza M, et al. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double blind study. Eur J Neurol 2006 Sep;13(9):981-5.

– Miller LG, Freeman B. Possible subdural hematoma associated with Ginkgo biloba. J.Herbal Pharmacother., 2(2):57-63, 2002.

– Mills & Bone – Principles and practice of Phytotherapy. Modern Herbal Medicine,2ed. Churchill Livingstone, 2013.

– Naidu MU, Kumar KV, Mohan IK et al. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice. Indian J Exp Biol 2002.

– Oken BS et al. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998;55:1409-1415.

– Ozturk G, Anlar O, Erdogan E et al. The effect of Ginkgo extract EGB761 in cisplatininduced peripheral neuropathy in mice. Toxicol Appl Pharmacol 2004.
– Rigney U et al. The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother res 1999;13:408-415.

– Robertson SM, Davey RT, Voell J, et al. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in health subjects. Curr. Med. Res. Opion., 2008;24(2):591-599.

– Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108.

– Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775-1776.

– Schubert H. Depressive episode primarily unresponsive to therapy in elderly patients. Efficacy of Ginkgo biloba (Egb 761) in combination with antidepressants. Geriatr Forsch 1993;3:45-53.

– Trick L. The effects of Ginkgo biloba extract (LI 1370) supplementation and discontinuation on activities of daily living and mood in free living older volunteers. Phytother Res. 2004 Jul;18(7):531-7.

– Uchida S, Yamada H, Li XD, et al. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J. Clin. Pharmacol., 2006; 46:1290- 1298.

– Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [letter]. Lancet 1998;352.

– Varga E, Bodi A, Ferdinandy P et al. The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol 1999.

– Wettstein A. Cholinesterase inhibitors and Ginkgo extracts- are they comparable in the treatment of dementia? Comparison of published placebo-controleed efficacy studies of at least six months’ duration. Phytomedicine 2000;6:393-401.

– Yi SY, Nan KJ, Chen SJ. [Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;Jan;28(1):68-70.

Leave us a comment

Cart Item Removed. Undo
  • No products in the cart.